Total Reports
12
FDA CVM filings
Cat /
FDA CVM · 2025 release 12 reports on file
Chartreuse - FDA Adverse Event Profile
Adverse-event records for Chartreuse (Cat) from the FDA Center for Veterinary Medicine.
Data updated June 2026
The record at a glance
Among cat breeds, Chartreuse is #418 by FDA report volume; 16.7% of its 12 reports (2) were death-coded.
- #418
- most-reported cat breed
- 16.7%
- death-coded report share
- 3
- Vomiting - top reaction
- 7.1 yr
- average age at report
Higher volume usually means a more popular breed, not a riskier one, compare against how common the breed is.
Deaths Reported
2
of 12 reports
Death Rate
16.7%
death-coded share
Avg Age at Report
7.1 yr
5.5 kg avg weight
Death-Coded Outcome Share
Chartreuse death-coded reports 16.7%
Cross-breed median
16.7% of 12 chartreuse reports involved a death outcome.
How to read this number
Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (about 4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
Average weight at time of report: 5.5 kg (12.1 lbs)
Top Reported Reactions
Vomiting 3
Hyperpigmentation 1
Tongue disorder NOS 1
Inappetence 1
Dehydration 1
Most Referenced Drugs
Maropitant Citrate 2
Selamectin 2
Cefovecin 1
Cyclosporine A 1
Amoxicillin/ Clavulanic Acid 1
Outcome Breakdown
Outcome Unknown
5 (41.7%)
Recovered/Normal
4 (33.3%)
Ongoing
1 (8.3%)
Euthanized
1 (8.3%)
Died
1 (8.3%)
Gender Distribution
Female 6 (50.0%)
Male 6 (50.0%)
Reports by Year
| Year | Reports | Trend |
|---|---|---|
| 2012 | 1 | |
| 2013 | 3 | |
| 2014 | 2 | |
| 2015 | 2 | |
| 2019 | 2 | |
| 2020 | 1 | |
| 2025 | 1 | |
Chartreuse Pet Health Insights
Chartreuse accounts for 12 FDA adverse event reports, ranking #418 by volume among cat breeds, with 2 reports (16.7%) coded as a death outcome. Mean age at report: 7.1 years, average weight 5.5 kg (12.1 lbs).
Top reported signs: Vomiting (3), Hyperpigmentation (1), Tongue disorder NOS (1). Most-referenced drug: Maropitant Citrate (2 reports), followed by Selamectin (2) and Cefovecin (1).
Outcome coding on 12 status-recorded reports is dominated by Outcome Unknown (41.7%). Annual submissions ranged 2,012-2,025 across 7 years on file.
Cat Breeds With a Similar Report Volume
Frequently Asked Questions
How many FDA adverse event reports involve Chartreuse? ▼
There are 12 adverse event reports involving Chartreuse in the FDA database, with 2 reports involving death (16.7% death rate). Chartreuse ranks #418 by report volume.
What are the most common adverse reactions reported for Chartreuse? ▼
The most commonly reported adverse reactions for Chartreuse are Vomiting (3 reports), Hyperpigmentation (1 reports), Tongue disorder NOS (1 reports), Inappetence (1 reports), Dehydration (1 reports).
What drugs are most frequently associated with Chartreuse adverse events? ▼
The drugs most frequently referenced in Chartreuse adverse event reports are Maropitant Citrate (2 reports), Selamectin (2 reports), Cefovecin (1 reports), Cyclosporine A (1 reports), Amoxicillin/ Clavulanic Acid (1 reports).
What is the average age of Chartreuse in adverse event reports? ▼
The average age of Chartreuse at the time of adverse event reports is 7.1 years, with an average weight of 5.5 kg (12.1 lbs).
Does a high number of adverse event reports mean Chartreuse is unhealthy? ▼
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Chartreuse safety data come from? ▼
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.
Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how death rate and rankings are computed.
Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. Breed figures are computed directly from FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.